Back to Search Start Over

Eltrombopag second‐line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off‐treatment: results of a phase II, multicentre, prospective study.

Authors :
Lucchini, Elisa
Palandri, Francesca
Volpetti, Stefano
Vianelli, Nicola
Auteri, Giuseppe
Rossi, Elena
Patriarca, Andrea
Carli, Giuseppe
Barcellini, Wilma
Celli, Melania
Consoli, Ugo
Valeri, Federica
Santoro, Cristina
Crea, Enrico
Vignetti, Marco
Paoloni, Francesca
Gigliotti, Casimiro Luca
Boggio, Elena
Dianzani, Umberto
Giardini, Ilaria
Source :
British Journal of Haematology; Apr2021, Vol. 193 Issue 2, p386-396, 11p
Publication Year :
2021

Abstract

Summary: Up to 30% immune thrombocytopenia (ITP) patients achieve a sustained remission off‐treatment (SROT) after discontinuation of thrombopoietin receptor agonists (TPO‐RAs). Factors predictive of response are lacking. Patients aged ≥18 years with newly diagnosed or persistent ITP were treated with eltrombopag for 24 weeks. Primary end‐point was SROT: the proportion of responders that were able to taper and discontinue eltrombopag maintaining the response during a period of observation (PO) of six months. Secondary end‐points included the association between some immunological parameters (TPO serum levels, cytokines and lymphocyte subsets) and response. Fifty‐one patients were evaluable. Primary end‐point was achieved in 13/51 (25%) treated patients and 13/34 (38%) patients who started the tapering. Baseline TPO levels were not associated with response at week 24 nor with SROT. Higher baseline levels of IL‐10, IL‐4, TNF‐α and osteopontin were negative factors predictive of response (P = 0·001, 0·008, 0·02 and 0·03 respectively). This study confirms that SROT is feasible for a proportion of ITP patients treated with eltrombopag. Some biological parameters were predictive of response. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00071048
Volume :
193
Issue :
2
Database :
Complementary Index
Journal :
British Journal of Haematology
Publication Type :
Academic Journal
Accession number :
149844475
Full Text :
https://doi.org/10.1111/bjh.17334